TipRanks
Oaktree Specialty Lending (DE:FFC0)
FRANKFURT:FFC0
Germany Market
EarningsQ3 2026 Earnings Report

Oaktree Specialty Lending (FFC0) Q3 2026 Earnings Report

3 Followers

DE:FFC0 Q3 2026 EPS Results

Actual EPS€0.33
Consensus EPS€0.32
Beat/MissBeat by +€0.01
One Year Ago EPS€0.34

DE:FFC0 Q3 2026 Revenue Results

Actual Revenue€17.75M
Expected Revenue€61.92M
Beat/MissMissed by -€44.17M
YoY Revenue Growth-67.83%

Earnings Announcement Details

QuarterQ3 2026
Date08/05/2026
TimeBefore Open
Conference CallWednesday, August 5, 2026
DE:FFC0 Upcoming Earnings
Oaktree Specialty Lending's next earnings date is estimated for November 24, 2026, based on past reporting schedules.

Q3 2026 Earnings Call Audio

DE:FFC0 Q3 2026 Earnings Call
0:00 / 0:00

Q3 2026 Earnings Slide Deck

Q3 2026 Earnings Call Summary

Q3 2026
Earnings Call Date:Aug 05, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call presented several clear positives: meaningful progress reducing non‑accruals, a successful Thrasio workout, conservative leverage (net leverage ~1.02x), ample liquidity (~$699M), stable NAV, higher yields on new originations (10.0%) and improved portfolio operating metrics (median EBITDA +4%, interest coverage 2.4x). Offsetting these were modest near‑term headwinds: a small decline in adjusted NII, ~ $15M of realized losses, lower proceeds from exits, industry‑wide deal flow contraction and refinancing/AI risk concentrated in certain cohorts, and an upcoming $350M unsecured note maturity. On balance, the positive balance‑sheet and portfolio improvements and demonstrated workout capabilities outweigh the challenges discussed, but management remains cautious and focused on capital allocation and liquidity management.
Company Guidance
The call reiterated guidance to prioritize reducing non‑accruals and maintaining a flexible balance sheet: non‑accruals were ~1.8% of the debt portfolio at fair value (down 80 bps sequentially, 140 bps YoY and ~280 bps from the March 2025 peak), with 6 positions on non‑accrual after exiting 5 in the last two quarters (Thrasio repaid ~ $25M, ~80% of loans; remaining second‑out marked up from 80% to 99% and returned to accrual), while net leverage ended the quarter at ~1.02x (down from 1.04x), inside the 0.9x–1.25x target range, total debt was $1.45B, weighted average interest on debt 5.9%, unsecured debt 65% of total, available liquidity nearly $700M ($40M cash, $659M undrawn), unfunded commitments ~ $208M, and management plans to address $350M of unsecured notes maturing Jan 2027 over the next several quarters; third‑quarter operating metrics included adjusted total investment income $69.2M, adjusted net investment income $32.2M (~$0.37/sh) vs $33.7M ($0.38) prior, a $0.33/share dividend ($0.30 base + $0.03 supplemental), NAV $15.70 (stable), portfolio was 82% first‑lien senior secured with weighted average yield on debt investments 9.3% (new debt yield 10.0%), median EBITDA ~$189M, portfolio leverage 5.1x, interest coverage 2.4x, PIK ~7.8% of investment income, new commitments $206M (vs $204M), proceeds $263M (vs $334M), average position ~65 bps of the portfolio, and no single position >2.1%.
Material Reduction in Non-Accruals
Non-accruals were approximately 1.8% of the total debt portfolio at fair value, down 80 basis points sequentially and down 140 basis points year‑over‑year; management also noted a ~280 basis point decline from the March 2025 peak. Exited 5 non‑accrual positions in the last two quarters, leaving 6 investments on non‑accrual.
Thrasio Workout and Recoveries
Thrasio repaid ~$25 million (just over 80% of OCSL's loans): entire first‑out term loan paid off and ~75% of the second‑out repaid. Remaining second‑out was marked up from 80% to 99%, returned to accrual and expected to be fully repaid in the coming months — conversion of a non‑accrual into cash and an income‑producing loan.
Conservative and Flexible Balance Sheet
Net leverage ended the quarter at ~1.02x (down from 1.04x prior quarter) and below the midpoint of the 0.9x–1.25x target range. Available liquidity was nearly $700 million (approximately $699M), up about $30M quarter‑over‑quarter, including $40M cash and $659M undrawn capacity.
Stable NAV and Dividend Maintained
NAV per share was $15.70 as of June 30, 2026, essentially flat vs $15.69 at March 31, 2026. Board declared a total cash dividend of $0.33 per share (base $0.30 + supplemental $0.03) payable Sept 30, 2026.
Healthy New Origination Yield and Consistent Commitments
New investment commitments totaled $206M (stable vs $204M prior quarter). Weighted average yield on new debt investments increased to 10.0% from 9.2% in the prior quarter, reflecting higher spreads on new private originations.
Portfolio Quality and Diversification
82% of the portfolio at fair value was first‑lien senior secured debt. Weighted average yield on debt investments was 9.3%. No single position exceeded 2.1% of fair value and the average debt position represented ~65 basis points of the total portfolio at fair value.
Improved Operating Metrics Across Portfolio Companies
Median EBITDA of portfolio companies was ~$189M, up ~4% sequentially. Portfolio company weighted average leverage improved to 5.1x (from 5.2x) and interest coverage improved to 2.4x (from 2.1x).
Productive Joint Venture Performance
Joint ventures held ~$524M across 135 companies and generated aggregate returns on equity of ~11.3% during the quarter; management converted ~25% of the Kemper JV subordinated note into equity without material impact to total JV earnings.

DE:FFC0 Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Nov 24, 2026
2026 (Q4)
0.30 / -
0.366―
2026 (Q3)
0.32 / 0.33
0.339-2.63% (>-0.01)
2026 (Q2)
0.33 / 0.35
0.401-13.33% (-0.05)
2026 (Q1)
0.34 / 0.37
0.482-22.22% (-0.11)
2025 (Q4)
0.34 / 0.37
0.491-25.45% (-0.12)
2025 (Q3)
0.40 / 0.34
0.482-29.63% (-0.14)
2025 (Q2)
0.45 / 0.40
0.5-19.64% (-0.10)
2025 (Q1)
0.47 / 0.48
0.509-5.26% (-0.03)
2024 (Q4)
0.50 / 0.49
0.553-11.29% (-0.06)
2024 (Q3)
0.50 / 0.48
0.562-14.29% (-0.08)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed